1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

US FDA Checking Boxes On OTC Monograph Overhaul And In-Box For ACNU Switch Comments

‘Different’ OTC Space Coming From Monograph Program Reform, Proposed OTC Switch Changes

 
• By Malcolm Spicer

“Who would have said that, looking forward two or three years ago, we would be where we are now?” says FDA OTC office director Theresa Michele. Monograph reform and introducing “additional conditions for nonprescription use” options for NDA OTCs each is a “real gamechanger.”

• Source: Shutterstock

The Food and Drug Administration’s regulation of the US OTC drug space is being overhauled through changes to its monograph program made within deadlines set by Congress and a proposal to extend labeling for nonprescription drugs into the digital realm.

However, what access to nonprescription drugs will look like after monograph reform is completed and if “additional conditions for nonprescription...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By David Ridley

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

FDA Takes World Tour In Recent OTC Warnings

 
• By Malcolm Spicer

FDA Center for Drug Evaluation and Research Office of Manufacturing Quality, Office of Compliance and Office of Unapproved Drugs & Labeling Compliance recently advise Indian, Canadian and US firms about GMP problems.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By David Ridley

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.